Leptin antagonist ameliorates chronic colitis in IL-10(−/−) mice

Por Singh, Udai P., Singh, Narendra P., Guan, Hongbing, Busbee, Brandon, Price, Robert L., Taub, Dennis D., Mishra, Manoj K., Fayad, Raja, Nagarkatti, Mitzi, Nagarkatti, Prakash S.
Publicado em 2013

The Emerging Role of Leptin Antagonist as Potential Therapeutic Option for Inflammatory Bowel Disease

Por Singh, Udai P., Singh, Narendra P., Guan, Hongbing, Busbee, Brandon, Price, Robert L., Taub, Dennis D., Mishra, Manoj K., Fayad, Raja, Nagarkatti, Mitzi, Nagarkatti, Prakash S.
Publicado em 2013

Alternative Medicines as Emerging Therapies for Inflammatory Bowel Diseases

Por Singh, Udai P., Singh, Narendra P., Busbee, Brandon, Guan, H., Singh, Balwan, Price, Robert L., Taub, Dennis D., Mishra, Manoj K., Nagarkatti, Mitzi, Nagarkatti, Prakash S.
Publicado em 2012

CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome and short-chain fatty acids

Por Chitrala, Kumaraswamy Naidu, Guan, Hongbing, Singh, Narendra P., Busbee, Brandon, Gandy, Alexa, Mehrpouya-Bahrami, Pegah, Ganewatta, Mitra S., Tang, Chuanbing, Chatterjee, Saurabh, Nagarkatti, Prakash, Nagarkatti, Mitzi
Publicado no Eur J Immunol (2017)